Detalles de la búsqueda
1.
A Randomized Placebo-Controlled Efficacy Study of a Prime Boost Therapeutic Vaccination Strategy in HIV-1-Infected Individuals: VRI02 ANRS 149 LIGHT Phase II Trial.
J Virol
; 95(9)2021 04 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33568510
2.
Resistance profile and treatment outcomes in HIV-infected children at virological failure in Benin, West Africa.
J Antimicrob Chemother
; 73(11): 3143-3147, 2018 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30060186
3.
Efficacy, safety and patient-reported outcomes of ledipasvir/sofosbuvir in NS3/4A protease inhibitor-experienced individuals with hepatitis C virus genotype 1 and HIV coinfection with and without cirrhosis (ANRS HC31 SOFTRIH study).
HIV Med
; 19(3): 227-237, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29214737
4.
Self-reported patient history to assess hepatitis B virus serological status during a large screening campaign.
Epidemiol Infect
; 147: e16, 2018 Sep 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-30264683
5.
Risk of HIV transmission during combined ART initiation for HIV-infected persons with severe immunosuppression.
J Antimicrob Chemother
; 72(11): 3172-3176, 2017 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28961977
6.
Week 96 efficacy and safety of darunavir/ritonavir monotherapy vs. darunavir/ritonavir with two nucleoside reverse transcriptase inhibitors in the PROTEA trial.
HIV Med
; 18(1): 5-12, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27279571
7.
Usefulness of Dried Blood Spots (DBS) to perform hepatitis C virus genotyping in drug users in Senegal.
J Med Virol
; 89(3): 484-488, 2017 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-26705258
8.
Clinical and microbiological determinants of severe and fatal outcomes in patients infected with Enterobacteriaceae producing extended-spectrum ß-lactamase.
Eur J Clin Microbiol Infect Dis
; 36(7): 1261-1268, 2017 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-28181033
9.
Efficacy of protease inhibitor monotherapy vs. triple therapy: meta-analysis of data from 2303 patients in 13 randomized trials.
HIV Med
; 17(5): 358-67, 2016 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-26709605
10.
Intensification with pegylated interferon during treatment with tenofovir in HIV-hepatitis B virus co-infected patients.
J Viral Hepat
; 23(12): 1017-1026, 2016 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-27486094
11.
Acquisition of carbapenemase-producing Enterobacteriaceae by healthy travellers to India, France, February 2012 to March 2013.
Euro Surveill
; 19(14)2014 Apr 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-24739981
12.
Polylactic acid vs. polyacrylamide hydrogel for treatment of facial lipoatrophy: a randomized controlled trial [Agence Nationale de Recherches sur le SIDA et les Hépatites Virales (ANRS) 132 SMILE].
HIV Med
; 14(7): 410-20, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23432777
13.
Evolving microbiological epidemiology and high fetal mortality in 135 cases of bacteremia during pregnancy and postpartum.
Eur J Clin Microbiol Infect Dis
; 32(1): 107-13, 2013 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-22907333
14.
Investigation of the phototoxicity and cytotoxicity of naproxen, a non-steroidal anti-inflammatory drug, in human fibroblasts.
Photochem Photobiol Sci
; 12(5): 911-22, 2013 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-23478633
15.
Pooled week 96 results of the phase III DUET-1 and DUET-2 trials of etravirine: further analysis of adverse events and laboratory abnormalities of special interest.
HIV Med
; 13(7): 427-35, 2012 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-22413938
16.
Influence of alpha-1 glycoprotein acid concentrations and variants on atazanavir pharmacokinetics in HIV-infected patients included in the ANRS 107 trial.
Antimicrob Agents Chemother
; 54(2): 614-9, 2010 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-19995932
17.
Gag mutations can impact virological response to dual-boosted protease inhibitor combinations in antiretroviral-naïve HIV-infected patients.
Antimicrob Agents Chemother
; 54(7): 2910-9, 2010 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-20439606
18.
HIV/hepatitis B virus co-infection: current challenges and new strategies.
J Antimicrob Chemother
; 65(1): 10-7, 2010 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-19900950
19.
Long-term (96-week) follow-up of antiretroviral-naïve HIV-infected patients treated with first-line lopinavir/ritonavir monotherapy in the MONARK trial.
HIV Med
; 11(2): 137-42, 2010 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-19682100
20.
Longitudinal evaluation of viral interactions in treated HIV-hepatitis B co-infected patients with additional hepatitis C and D virus.
J Viral Hepat
; 17(1): 65-76, 2010 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-19682317